BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 33233487)

  • 1. Intestinal Anti-Inflammatory Activity of Terpenes in Experimental Models (2010-2020): A Review.
    Araruna ME; Serafim C; Alves Júnior E; Hiruma-Lima C; Diniz M; Batista L
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33233487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease.
    Guo BJ; Bian ZX; Qiu HC; Wang YT; Wang Y
    Ann N Y Acad Sci; 2017 Aug; 1401(1):37-48. PubMed ID: 28891095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terpenes: Modulating anti-inflammatory signaling in inflammatory bowel disease.
    Rivera Rodríguez R; Johnson JJ
    Pharmacol Ther; 2023 Aug; 248():108456. PubMed ID: 37247693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of hypoxia-inducible factor 1-alpha in inflammatory bowel disease.
    Yin J; Ren Y; Yang K; Wang W; Wang T; Xiao W; Yang H
    Cell Biol Int; 2022 Jan; 46(1):46-51. PubMed ID: 34658125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases.
    Retnakumar SV; Muller S
    Trends Mol Med; 2019 Jun; 25(6):516-537. PubMed ID: 30952481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Inflammatory Effect of Homo- and Heterodimers of Natural Enkephalinase Inhibitors in Experimental Colitis in Mice.
    Sobocińska M; Salaga M; Fichna J; Kamysz E
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33321720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Cigarette Smoking on the Gastrointestinal Tract Inflammation: Opposing Effects in Crohn's Disease and Ulcerative Colitis.
    Berkowitz L; Schultz BM; Salazar GA; Pardo-Roa C; Sebastián VP; Álvarez-Lobos MM; Bueno SM
    Front Immunol; 2018; 9():74. PubMed ID: 29441064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myosin Light Chain 9/12 Regulates the Pathogenesis of Inflammatory Bowel Disease.
    Yokoyama M; Kimura MY; Ito T; Hayashizaki K; Endo Y; Wang Y; Yagi R; Nakagawa T; Kato N; Matsubara H; Nakayama T
    Front Immunol; 2020; 11():594297. PubMed ID: 33584659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse.
    Carvalho ACA; Souza GA; Marqui SV; Guiguer ÉL; Araújo AC; Rubira CJ; Goulart RA; Flato UAP; Bueno PCDS; Buchaim RL; Barbalho SM
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyphenol supplementation as a complementary medicinal approach to treating inflammatory bowel disease.
    Biasi F; Astegiano M; Maina M; Leonarduzzi G; Poli G
    Curr Med Chem; 2011; 18(31):4851-65. PubMed ID: 21919842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol and inflammatory bowel disease: the evidence so far.
    Nunes S; Danesi F; Del Rio D; Silva P
    Nutr Res Rev; 2018 Jun; 31(1):85-97. PubMed ID: 29191255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse models of inflammatory bowel disease for investigating mucosal immunity in the intestine.
    Bamias G; Arseneau KO; Cominelli F
    Curr Opin Gastroenterol; 2017 Nov; 33(6):411-416. PubMed ID: 28901966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive lipids in inflammatory bowel diseases - From pathophysiological alterations to therapeutic opportunities.
    Alhouayek M; Ameraoui H; Muccioli GG
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Feb; 1866(2):158854. PubMed ID: 33157277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Effects of Anti-Inflammatory
    Cordeiro N; Freitas RHCN; Fraga CAM; Fernandes PD
    J Pharmacol Exp Ther; 2020 Sep; 374(3):420-427. PubMed ID: 32546529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the immunological effects of food bioactive peptides in animal models of intestinal inflammation.
    de Medina FS; Daddaoua A; Requena P; Capitán-Cañadas F; Zarzuelo A; Dolores Suárez M; Martínez-Augustin O
    Proc Nutr Soc; 2010 Aug; 69(3):454-62. PubMed ID: 20598199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure–activity relationship of terpenes with anti-inflammatory profile – a systematic review.
    Souza MT; Almeida JR; Araujo AA; Duarte MC; Gelain DP; Moreira JC; dos Santos MR; Quintans-Júnior LJ
    Basic Clin Pharmacol Toxicol; 2014 Sep; 115(3):244-56. PubMed ID: 25275147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coumarin Derivatives in Inflammatory Bowel Disease.
    Di Stasi LC
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33467396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of flavonoids in inflammatory bowel disease: A comprehensive review.
    Salaritabar A; Darvishi B; Hadjiakhoondi F; Manayi A; Sureda A; Nabavi SF; Fitzpatrick LR; Nabavi SM; Bishayee A
    World J Gastroenterol; 2017 Jul; 23(28):5097-5114. PubMed ID: 28811706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.